📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
40
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for LYEL.
💹 Market Data
Market Cap$404.38M
Shares Outstanding23.33M
Float10.39M
Cash$254.02M
Debt$48.85M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 12.4% shares (2025Q4 vs prior)
69 institutional holders · 11.50M shares
#1
ARCH Venture Management, LLC
2.76M shares
#2
GSK plc
1.51M shares
#3
MWG Caph Ltd
1.01M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.34M
Days to Cover23.2
% of Float12.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
EFFECT
EFFECT
Apr 14, 2026
S-3
SHELF
Apr 03, 2026
3
FORM3
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for LYEL
📊 LYEL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 LYEL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.